Pharvaris N.V.
PHVS$2.32B
Mid CapNASDAQPharmaceutical Preparations🇺🇸North AmericaLEIDEN118 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Aug 2026
Market Overview
Stock performance and key metrics
PHVS News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Deucrictibant | Phase 3 | Hereditary Angioedema | - | - |
Deucrictibant low dose | Phase 2 | Hereditary Angioedema | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply